Showing 1 - 20 results of 20 for search 'Tobias Gedde‐Dahl', query time: 0.08s
Refine Results
-
1
A VH4-34+ myeloma protein with weak autoreactivity by Marianne Frøyland, Keith M. Thompson, Susan J. Thorpe, Surinder S. Sahota, Tobias Gedde-Dahl, Bjarne Bogen
Published 2007-05-01
Article -
2
-
3
-
4
The function of the complement system remains fully intact throughout the course of allogeneic stem cell transplantation by Beatrice Fageräng, Beatrice Fageräng, Leon Cyranka, Camilla Schjalm, Karin Ekholt McAdam, Carina Sandem Larsen, Julia Heinzelbecker, Tobias Gedde-Dahl, Tobias Gedde-Dahl, Reinhard Würzner, Terje Espevik, Geir Erland Tjønnfjord, Geir Erland Tjønnfjord, Peter Garred, Andreas Barratt-Due, Tor Henrik Anderson Tvedt, Tom Eirik Mollnes, Tom Eirik Mollnes
Published 2024-06-01
Article -
5
Improved outcome in patients following autologous stem cell transplantation for multiple myeloma in south eastern Norway 2001–2010: a retrospective, population based analysis by Jon-Magnus Tangen, Geir Erland Tjønnfjord, Nina Gulbrandsen, Tobias Gedde-Dahl, Espen Stormorken, Kristina Anderson, Camilla Dao Vo, Fredrik Hellem Schjesvold, For Oslo Myeloma Center
Published 2018-08-01
Article -
6
Familial/Bilateral and Sporadic Testicular Germ Cell Tumors Show Frequent Genetic Changes at Loci with Suggestive Linkage Evidence by Rolf I. Skotheim, Sigrid M. Kraggerud, Sophie D. Fosså, Anna E. Stenwig, Tobias Gedde-Dahl, jr., Håvard E. Danielsen, Kjetill S. Jakobsen, Ragnhild A. Lothe
Published 2001-01-01
Article -
7
Runaway Train: A Leaky Radiosensitive SCID with Skin Lesions and Multiple Lymphomas by Børre Fevang, Unn Merete Fagerli, Hanne Sorte, Harald Aarset, Håkon Hov, Marit Langmyr, Thomas Morten Keil, Ellen Bjørge, Pål Aukrust, Asbjørg Stray-Pedersen, Tobias Gedde-Dahl
Published 2018-01-01
Article -
8
Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors by B. Linder Grønvold, Maryan Mohamed Ali, Tor Å Myklebust, Andrea Lenartova, Mats Remberger, Ingerid Weum Abrahamsen, Geir Erland Tjønnfjord, Anders Eivind Myhre, Yngvar Fløisand, Tobias Gedde‐Dahl
Published 2024-02-01
Article -
9
Incidence and outcome of central nervous system relapse after hematopoietic stem cell transplantation in patients suffering from acute myeloid leukemia and acute lymphoblastic leuk... by Sabine Blum, Yves Chalandon, Myriam Labopin, Jürgen Finke, Tobias Gedde-Dahl, Tarek Ben Othman, Jan J. Cornelissen, Pavel Jindra, Hélène Labussière-Wallet, Matthew Collin, Stig Lenhoff, Guido Kobbe, Norma C. Gutiérrez, Arnon Nagler, Mohamad Mohty
Published 2024-03-01
Article -
10
Autologous stem cell transplantation (ASCT) for acute myeloid leukemia in patients in first complete remission after one versus two induction courses: A study from the ALWP of the... by Arnon Nagler, Jacques‐Emmanuel Galimard, Myriam Labopin, Didier Blaise, William Arcese, Silvia Maria Trisolini, Depei Wu, Arnaud Pigneux, Gwendolyn Van Gorkom, Marie‐Thérèse Rubio, Tobias Gedde‐Dahl, Anne Huynh, Francesco Lanza, Norbert‐Claude Gorin, Mohamad Mohty
Published 2023-01-01
Article -
11
PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation by Olaf Penack, Mouad Abouqateb, Christophe Peczynski, William Boreland, Zafer Gülbas, Tobias Gedde-Dahl, Cristina Castilla-Llorente, Nicolaus Kröger, Mathias Eder, Alessandro Rambaldi, Francesca Bonifazi, Igor Wolfgang Blau, Matthias Stelljes, Peter Dreger, Ivan Moiseev, Hélène Schoemans, Christian Koenecke, Zinaida Peric
Published 2024-03-01
Article -
12
Allogeneic stem cell transplantation in second complete remission for core binding factor acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Soci... by Kazimierz Halaburda, Myriam Labopin, Audrey Mailhol, Gerard Socié, Charles Craddock, Mahmoud Aljurf, Dietrich Beelen, Jan J. Cornelissen, Jean-Henri Bourhis, Hélène Labussière-Wallet, Didier Blaise, Tobias Gedde-Dahl, Maria Gilleece, Ibrahim Yakoub-Agha, Ghulam Mufti, Jordi Esteve, Mohamad Mohty, Arnon Nagler
Published 2020-06-01
Article -
13
Allogeneic hematopoietic cell transplantation in acute myeloid leukemia with normal karyotype and isolated Nucleophosmin-1 (NPM1) mutation: outcome strongly correlates with disease... by Ali Bazarbachi, Myriam Labopin, Mohamed A. Kharfan-Dabaja, Rainer Schwerdtfeger, Liisa Volin, Jean Henri Bourhis, Gérard Socié, Etienne Daguindau, Tobias Gedde-Dahl, Alessandro Rambaldi, Michal Karas, Günter Schlimok, Didier Blaise, Patrice Chevallier, Florent Malard, Christoph Schmid, Jordi Esteve, Arnon Nagler, Mohamad Mohty
Published 2016-01-01
Article -
14
Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT by Yishan Ye, Myriam Labopin, Jia Chen, Depei Wu, Tobias Gedde-Dahl, Didier Blaise, Gérard Socie, Edouard Forcade, Urpu Salmenniemi, Sébastien Maury, Jurjen Versluis, Ali Bazarbachi, Arnon Nagler, Eolia Brissot, Lin Li, Yi Luo, Jimin Shi, Fabio Ciceri, He Huang, Mohamad Mohty, Norbert Claude Gorin
Published 2024-05-01
Article -
15
Allogeneic bone marrow transplantation for patients with treatment-refractory Crohn's Disease by George B. McDonald, Ole J.B. Landsverk, Dermot P.B. McGovern, Anders Aasebø, Vemund Paulsen, Talin Haritunians, Henrik M. Reims, Bernadette M. McLaughlin, Timothy Zisman, Dalin Li, Elisabeth T.M.M. Elholm, Frode L. Jahnsen, George E. Georges, Tobias Gedde-Dahl
Published 2024-01-01
Article -
16
IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia by Jani Huuhtanen, Mette Ilander, Bhagwan Yadav, Olli M.J. Dufva, Hanna Lähteenmäki, Tiina Kasanen, Jay Klievink, Ulla Olsson-Strömberg, Jesper Stentoft, Johan Richter, Perttu Koskenvesa, Martin Höglund, Stina Söderlund, Arta Dreimane, Kimmo Porkka, Tobias Gedde-Dahl, Björn T. Gjertsen, Leif Stenke, Kristina Myhr-Eriksson, Berit Markevärn, Anna Lübking, Andreja Dimitrijevic, Lene Udby, Ole Weis Bjerrum, Henrik Hjorth-Hansen, Satu Mustjoki
Published 2022-09-01
Article -
17
Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT by Joanna Drozd-Sokolowska, Luuk Gras, Linda Koster, Rodrigo Martino, María Queralt Salas, Urpu Salmenniemi, Teresa Zudaire, Lucrecia Yañez, Mar Bellido, Matthew Collin, Martin Kaufmann, Piotr Kozlowski, Xavier Poiré, Christelle Ferra, Antònia Sampol, Keith M. O. Wilson, Anne Cairoli, Tobias Gedde-Dahl, Eric Deconinck, Milena Mirabile, Felipe Suarez, Kavita Raj, Michel van Gelder, Ibrahim Yakoub-Agha, Olivier Tournilhac, Donal P. McLornan
Published 2024-01-01
Article -
18
Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukemia treated with nilotinib by Stein-Erik Gullaksen, Jørn Skavland, Sonia Gavasso, Vinko Tosevski, Krzysztof Warzocha, Claudia Dumrese, Augustin Ferrant, Tobias Gedde-Dahl, Andrzej Hellmann, Jeroen Janssen, Boris Labar, Alois Lang, Waleed Majeed, Georgi Mihaylov, Jesper Stentoft, Leif Stenke, Josef Thaler, Noortje Thielen, Gregor Verhoef, Jaroslava Voglova, Gert Ossenkoppele, Andreas Hochhaus, Henrik Hjorth-Hansen, Satu Mustjoki, Sieghart Sopper, Francis Giles, Kimmo Porkka, Dominik Wolf, Bjørn Tore Gjertsen
Published 2017-08-01
Article -
19
Robust spike-specific CD4+ and CD8+ T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort study by Lorenzo Federico, Lorenzo Federico, Tor Henrik Anderson Tvedt, Murat Gainullin, Murat Gainullin, Julie Røkke Osen, Julie Røkke Osen, Viktoriia Chaban, Viktoriia Chaban, Katrine Persgård Lund, Katrine Persgård Lund, Lisa Tietze, Lisa Tietze, Trung The Tran, Trung The Tran, Fridtjof Lund-Johansen, Fridtjof Lund-Johansen, Hassen Kared, Hassen Kared, Andreas Lind, John Torgils Vaage, John Torgils Vaage, Richard Stratford, Simen Tennøe, Brandon Malone, Trevor Clancy, Anders Eivind Leren Myhre, Anders Eivind Leren Myhre, Tobias Gedde-Dahl, Ludvig André Munthe, Ludvig André Munthe
Published 2023-07-01
Article -
20
Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation by Annalisa Ruggeri, Liesbeth C. de Wreede, Carlheinz R. Müller, Pietro Crivello, Edouard F. Bonneville, Effie W. Petersdorf, Gerard Socié, Valérie Dubois, Riitta Niittyvuopio, Juha Peräsaari, Ibrahim Yakoub-Agha, Jan J. Cornelissen, Lotte Wieten, Tobias Gedde-Dahl, Edouard Forcade, Charles R. Crawley, Steven G.E. Marsh, Virginie Gandemer, Eleni Tholouli, Claude-Eric Bulabois, Anne Huynh, Goda Choi, Eric Deconinck, Maija Itäla-Remes, Stig Lenhoff, Mats Bengtsson, Jan-Erik Johansson, Gwendolyn van Gorkom, Jorinde D. Hoogenboom, Luca Vago, Vanderson Rocha, Chiara Bonini, Christian Chabannon, Katharina Fleischhauer
Published 2022-05-01
Article